Soleno Therapeutics (SLNO) Capital Expenditures (QoQ) (2015 - 2026)
Soleno Therapeutics (SLNO) Capital Expenditures (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.10% |
| Dec 31, 2025 | 5,700.00% |
| Sep 30, 2025 | -92.86% |
| Dec 31, 2024 | -95.81% |
| Sep 30, 2024 | 2,287.50% |
| Jun 30, 2024 | -27.27% |
| Dec 31, 2021 | 160.00% |
| Mar 31, 2021 | 300.00% |
| Jun 30, 2019 | -40.00% |
| Mar 31, 2019 | 400.00% |
| Dec 31, 2018 | -60.00% |
| Dec 31, 2017 | -200.18% |
| Sep 30, 2017 | 57,100.00% |
| Jun 30, 2017 | -125.00% |
| Mar 31, 2017 | 111.69% |
| Dec 31, 2016 | -217.95% |
| Sep 30, 2016 | 2,800.00% |
| Jun 30, 2016 | -94.74% |
| Mar 31, 2016 | 108.50% |
| Dec 31, 2015 | -178.75% |